Market Cap
$403.3M
CYH
COMMUNITY HEALTH SYSTEMS INC
$2.72 ▼ -1.09%
Prev close $2.75Market cap$403.3M
ConsensusStrong Sell
12-mo target$3.16 (+16.0%)
▼ Bearish
Analyst conviction 1/10
High Impact Filing (7/10)19 New Institutional Positions13 Institutional Exits Healthcare & Medical Devices
Snapshot
The big-picture read on CYH right now — valuation, ownership and activity at a glance.
Cap Size
Small Cap
Analyst Consensus
Sell (13%)
Inst. Holders
50 funds
Inst. Value
$206.1M
Inst. Activity
19 buys / 13 sells
Insider Activity
$0.00 buy / $118.4K sell
Insider Net $
-$118.4K
SEC Reports
3
Price chart 30d -6.5%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 1, 2026 short_volume
Short Volume: CYH — 61.9% short (0.4M / 0.6M)
Short: 388,307 | Exempt: 75 | TRF Vol: 627,558 | Short Ratio: 61.9% | Off-exchange volume (dark pool
Aug 25, 2026 Insider
JENNINGS WILLIAM NORRIS sold 40,000 shares
Director @ $2.96 ($118.4K)
Jun 30, 2026 Insider
Krishnan K Ranga acquired via exercise 13,930 shares
Director
Jun 30, 2026 Insider
Krishnan K Ranga acquired via exercise 13,930.678 shares
Director
Jun 30, 2026 Inst.
BANK OF AMERICA CORP — DOUBLED
1,767,619 shares ($5.9M)
Jun 30, 2026 Inst.
Jun 1, 2026 SEC GOLDMAN SACHS GROUP INC — TRIM
1,756,908 shares ($5.9M)
Community Health Systems (CYH) completed the sale of four Arkansas hospitals (Northwest Medical Center - Bentonville, No
8-K — Impact 5/10
Community Health Systems (CYH) reported Q1 2026 earnings with a net loss of $0.43 per share on $2.965B revenue, missing
8-K — Impact 7/10
Analyst ratings buy % +8.3%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
13% rate it Buy or better · 16 analysts
Recent analyst actions
| Date | Firm | Action | Rating | Firm rating |
|---|---|---|---|---|
| Sep 23, 2026 | BMO Capital | INITIATE | Market Perform | 53% |
| Jul 27, 2026 | RBC Capital | MAINTAIN | Outperform | 55% |
| Jul 27, 2026 | Truist Securities | MAINTAIN | Hold | 55% |
| Jul 25, 2026 | UBS | MAINTAIN | Neutral | 55% |
| Jul 23, 2026 | Barclays | MAINTAIN | Underweight | 54% |
| Jul 14, 2026 | Truist Securities | MAINTAIN | Hold | 55% |
| Jul 8, 2026 | Barclays | DOWNGRADE | Underweight | 54% |
| Apr 23, 2026 | Truist Securities | MAINTAIN | Hold | 55% |
| Apr 23, 2026 | Barclays | MAINTAIN | Equal-Weight | 54% |
| Apr 13, 2026 | Truist Securities | MAINTAIN | Hold | 55% |
Monthly consensus history
| Period | Str. Buy | Buy | Hold | Sell | Str. Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | 1 | 1 | 6 | 7 | 1 | 13% | |
| Aug 1, 2026 | 1 | 1 | 6 | 7 | 1 | 13% | |
| Jul 1, 2026 | 1 | 1 | 7 | 6 | 1 | 13% | |
| Jun 1, 2026 | 1 | 1 | 7 | 6 | 1 | 13% | |
| May 1, 2026 | 1 | 1 | 7 | 6 | 1 | 13% | |
| Apr 1, 2026 | 1 | 1 | 8 | 6 | 1 | 12% | |
| Mar 1, 2026 | 1 | 1 | 8 | 6 | 1 | 12% | |
| Feb 1, 2026 | 1 | 1 | 8 | 6 | 1 | 12% |
Price targets
Where 8 covering analysts think CYH trades over the next 12 months.
$3.16 +16.0% upside Buy
Current$2.72 Low$2.00 Median$3.13 High$4.00 8 analysts
$2.00$4.00
Analyst rating Hold· 3.1/5 as of Oct 2, 2026
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
3 SEC filing reports analyzed · 0 bullish, 1 bearish, 0 mixed, 2 neutral · avg impact 5.7/10.
NEUTRAL8-K5/10
Community Health Systems (CYH) completed the sale of four Arkansas hospitals (Northwest Medical Cent
Jun 1, 2026
BEARISH8-K7/10
Community Health Systems (CYH) reported Q1 2026 earnings with a net loss of $0.43 per share on $2.96
Apr 21, 2026
NEUTRAL8-K5/10
Community Health Systems (CYH) has agreed to sell four Arkansas hospitals and related assets to Free
Mar 5, 2026
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Oct 1, 2026
short_volume
Short Volume: CYH — 61.9% short (0.4M / 0.6M)
Short: 388,307 | Exempt: 75 | TRF Vol: 627,558 | Short Ratio: 61.9% | Off-exchange volume (dark pool + OTC)
Sep 9, 2026
short_volume
Short Volume: CYH — 70.7% short (0.4M / 0.6M)
Short: 397,828 | Exempt: 0 | TRF Vol: 563,069 | Short Ratio: 70.7% | Off-exchange volume (dark pool + OTC)
Aug 28, 2026
short_volume
Short Volume: CYH — 85.5% short (0.6M / 0.7M)
Short: 580,334 | Exempt: 0 | TRF Vol: 679,123 | Short Ratio: 85.5% | Off-exchange volume (dark pool + OTC)
Jul 31, 2026
short_volume
Short Volume: CYH — 71.8% short (0.6M / 0.8M)
Short: 591,699 | Exempt: 241 | TRF Vol: 824,376 | Short Ratio: 71.8% | Off-exchange volume (dark pool + OTC)
Jul 30, 2026
short_volume
Short Volume: CYH — 66.1% short (0.5M / 0.8M)
Short: 533,271 | Exempt: 252 | TRF Vol: 806,591 | Short Ratio: 66.1% | Off-exchange volume (dark pool + OTC)
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Current Q | $-0.32 | $-0.39–$-0.23 | -125.5% | +0.0% | 0↑ 4↓ | $2.8B | 5 |
| Next Q | $-0.17 | $-0.27–$-0.09 | 0.0% | +0.0% | 0↑ 4↓ | $2.9B | 6 |
| Current FY | $-1.17 | $-1.23–$-1.11 | -198.0% | +0.0% | 0↑ 4↓ | $11.4B | 5 |
| Next FY | $-0.52 | $-0.81–$-0.35 | 55.6% | +0.0% | 0↑ 7↓ | $11.5B | 7 |
Current-quarter EPS estimate — revision history
| When | EPS estimate | Change vs now |
|---|---|---|
| Current | $-0.324 | — |
| 7d ago | $-0.324 | — |
| 30d ago | $-0.324 | — |
| 60d ago | $-0.305 | -0.019 |
| 90d ago | $-0.034 | -0.290 |
Institutional ownership
Which big funds own CYH (from quarterly 13F filings) and who is adding or trimming.
50 institutional holders with $206.1M total value (61,706,204 shares) as of 2026-Q2. Top holders: BlackRock,, NOMURA, VANGUARD. Net buying activity: 19 institutions added/increased vs 13 reduced.
Top holders — 2026-Q2
| Fund | Shares | Value | % Tracked | Last move |
|---|---|---|---|---|
| BlackRock, Inc. | 10,930,538 | $36.5M | 17.7% | — |
| NOMURA HOLDINGS INC | 6,703,109 | $22.4M | 10.9% | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 5,289,931 | $17.7M | 8.6% | — |
| GEODE CAPITAL MANAGEMENT, LLC | 3,167,702 | $10.6M | 5.1% | — |
| STATE STREET CORP | 3,061,863 | $10.2M | 5.0% | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 3,018,598 | $10.1M | 4.9% | — |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2,448,018 | $8.2M | 4.0% | — |
| DIMENSIONAL FUND ADVISORS LP | 2,351,460 | $7.9M | 3.8% | — |
| D. E. Shaw & Co., Inc. | 2,344,128 | $7.8M | 3.8% | — |
| AQR CAPITAL MANAGEMENT LLC | 2,290,827 | $7.7M | 3.7% | — |
Recent position changes
| Fund | Action | Prev | Current | Change | Value |
|---|---|---|---|---|---|
| BANK OF AMERICA CORP /DE/ | DOUBLED | 594,115 | 1,767,619 | +197.5% | $5.9M |
| GOLDMAN SACHS GROUP INC | TRIM | 2,729,969 | 1,756,908 | -35.6% | $5.9M |
| CITADEL ADVISORS LLC | ADD | 617,038 | 1,040,527 | +68.6% | $3.5M |
| MARSHALL WACE, LLP | TRIM | 1,776,379 | 570,831 | -67.9% | $1.9M |
| MILLENNIUM MANAGEMENT LLC | DOUBLED | 35,908 | 509,455 | +1318.8% | $1.7M |
| ExodusPoint Capital Management, LP | ADD | 397,691 | 498,384 | +25.3% | $1.7M |
| UBS Group AG | TRIM | 368,336 | 254,817 | -30.8% | $851.1K |
| IEQ CAPITAL, LLC | DOUBLED | 48,915 | 196,995 | +302.7% | $658.0K |
| WELLS FARGO & COMPANY/MN | DOUBLED | 51,915 | 113,738 | +119.1% | $379.9K |
| CITIGROUP INC | DOUBLED | 36,418 | 103,711 | +184.8% | $346.4K |
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
17 insiders, 50 transactions. Net -$118.4K — $0.00 bought, $118.4K sold.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 25, 2026 | JENNINGS WILLIAM NORRIS | Director | SELL | 40,000 | $2.96 | $118.4K |
| Jun 30, 2026 | Krishnan K Ranga | Director | EXERCISE | 13,930 | — | — |
| Jun 30, 2026 | Krishnan K Ranga | Director | EXERCISE | 13,930.678 | — | — |
| Jun 1, 2026 | Rice David V. | EVP-Clinical Operations & CMO | AWARD | 30,000 | — | — |
| Jun 1, 2026 | Rice David V. | EVP-Clinical Operations & CMO | AWARD | 30,000 | — | — |
| Jun 1, 2026 | Rice David V. | EVP-Clinical Operations & CMO | AWARD | 30,000 | — | — |
| Apr 22, 2026 | Krishnan K Ranga | Director | EXERCISE | 46,950 | — | — |
| Mar 2, 2026 | SMITH WAYNE T | Director | GIFT | 19,400 | — | — |
| Mar 1, 2026 | HAMMONS KEVIN J | CEO | D | 23,760 | — | — |
| Mar 1, 2026 | HAMMONS KEVIN J | CEO | AWARD | 400,000 | — | — |
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for CYH.
Shares short
13,549,537
Settlement Sep 15, 2026
Change vs prior
+2.9%
Semi-monthly cycle
Days to cover
12.6
At avg daily volume
Of shares outstanding
≈9.6%
Estimate — not % of float
All CYH filing & press-release reports (3)
- 8-K reportJun 1, 2026
- 8-K reportApr 21, 2026
- 8-K reportMar 5, 2026